figshare
Browse
Table 4.xls (5.5 kB)

Adjusted odds ratios (OR) of clinical parameters included for most accurate designation of subjects discontinuing treatment due to pulmonary adverse effects.

Download (5.5 kB)
dataset
posted on 2018-12-12, 18:57 authored by Kerstin Pohl, David P. Nichols, Jennifer L. Taylor-Cousar, Milene T. Saavedra, Matthew J. Strand, Jerry A. Nick, Preston E. Bratcher

Adjusted odds ratios (OR) of clinical parameters included for most accurate designation of subjects discontinuing treatment due to pulmonary adverse effects.

History

Usage metrics

    PLOS ONE

    Categories

    Keywords

    lung functionfibrosis transmembrane conductance regulatorleukocyte surface antigensCXCR 2 levelsF 508del CFTR mutation Cystic fibrosisF 508del mutationdiscontinuationpotentiates CFTR functionColorado Adult CF Programlumatreatment initiation

    Licence

    CC BY 4.0

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC